2023 annual financial data
Autolus Therapeutics 2023 Net income growth
Direct answer
Net income growth was -40.01%.
Operating income was -179,701,000 USD and net income was -208,383,000 USD.
Operating cash flow was -145,587,000 USD.
Get free Autolus Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,698,000 USD
- Operating income
- -179,701,000 USD
- Net income
- -208,383,000 USD
- Operating cash flow
- -145,587,000 USD